#antibody

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a ...

RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of ...

The Jakarta Health Office has appealed to breastfeeding women to get vaccinated to reduce the risk of COVID-19 ...

Mothers who test positive for COVID-19 can breastfeed their babies, a Health Ministry nutritionist has said at an event ...

Dissemination of information pertaining to the benefits and importance of convalescent plasma donation should be ...

Identifying asymptomatic COVID-19 patients and monitoring the spread of the virus in the environment is difficult, ...

An epidemiologist at the Faculty of Public Health, University of Indonesia (FKM-UI) Pandu Riono, at a discussion ...

The West Java provincial government has begun offering medicine and vitamin assistance for COVID-19 patients conducting ...

Families have an important role to play as a bulwark against the spread of coronavirus infections, Minister of Home ...

Amid rising concerns over the threat and economic impact of COVID-19, Holista Colltech Ltd ("Holista") has been ...

infected animals was confirmed with a clinical dosage of regdanvimab (CT-P59)1 Incheon, South Korea--(Antara/Business ...

Erick Thohir, Minister of State Enterprises (SOEs), said he is eager to see Indonesia produce its own vaccines under ...

Celltrion Group today announced that CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate, has confirmed ...

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral ...